Abstract
Social media, online social networks and apps for smartphones and tablets are changing the way to communicate health and health issues to consumers and health professionals. Google, Facebook, Apple, and other companies have launched tools to make easier the doctor-patient communication, to group patients with similar diseases allowing them to share stories, experiences, and opinions, and to remotely track and monitor users health and wellbeing. However several concerns about patients' and consumers' privacy remain. Doctor-patient communication through e-mail and social media also introduces other ethical and privacy issues that were addressed only by few medical societies with appropriate guidelines and policies. In addition, pharmaceutical companies have started to use social media channels to communicate with doctors, patients and consumers. This type of communication has been only partially regulated by the Food and Drug Administration with the recently published guidelines for industries. Similar concerns exist for health and medical applications for smartphones and tablets for which only few agencies (including Food and Drug Administration) are requiring a formal (even if restricted in typology) validation. It's time for Europe and Italy to adopt appropriate guidelines for the use of the new media in health communication.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.